Jasveen Sangha Sentenced to 15 Years in Perry Ketamine Case
A federal judge has sentenced Jasveen Sangha to 15 years in prison for her role in a ketamine distribution network that supplied the drug to actor Matthew Perry prior to his death in October 2023. Sangha pleaded guilty to five felony drug charges last year. Four other individuals have also pleaded guilty in connection with the case.
Sentencing and Legal Proceedings
On Wednesday, U.S. District Judge Sherilyn Garnett imposed a 15-year prison term on Jasveen Sangha, 42, a dual U.S.-British citizen. Sangha had been in custody since her arrest in August 2024. She faced a maximum potential sentence of 65 years.
In September, Sangha pleaded guilty to one count of maintaining a drug-involved premises, three counts of illegal distribution of ketamine, and one count of distribution of ketamine resulting in death or serious bodily injury.
Federal prosecutors recommended the 15-year sentence. In court filings, they described Sangha as operating a "high-volume drug trafficking business" from her North Hollywood residence since at least 2019, distributing ketamine and methamphetamine.
Prosecutors argued she continued her activities after learning that ketamine she supplied contributed to two overdose deaths: Matthew Perry's in 2023 and that of another individual, Cody McLaury, in 2019.
Sangha's defense attorneys requested a sentence of time already served, citing her "demonstrated rehabilitation," sustained sobriety, and participation in recovery programs since her arrest.
During the sentencing hearing, Sangha stated she took "full responsibility" for her actions and expressed shame for their impact on the families involved. Victim impact statements were delivered by members of Matthew Perry's family.
The Death of Matthew Perry
Matthew Perry, 54, was found deceased in a hot tub at his Los Angeles home on October 28, 2023.
A subsequent autopsy report concluded the cause of death was the "acute effects of ketamine." Contributing factors listed were the effects of buprenorphine (a medication used to treat opioid use disorder), drowning, and coronary artery disease.
Perry had a publicly known history of substance abuse. According to federal law enforcement officials, he had been receiving medically supervised ketamine infusion therapy for depression and anxiety prior to his death.
The Drug Supply Chain
Court documents and plea agreements outline the following sequence of events:
- Jasveen Sangha admitted to selling 51 vials of ketamine to co-defendant Erik Fleming.
- Fleming then sold the ketamine to Matthew Perry's live-in personal assistant, Kenneth Iwamasa.
- Prosecutors state that on October 28, 2023, Iwamasa injected Perry with at least three doses of ketamine from the vials supplied by Sangha and Fleming.
- Sangha acknowledged knowing the ketamine she sold to Fleming was intended for Matthew Perry.
Other Defendants
Four other individuals pleaded guilty to federal drug offenses in connection with the case:
- Erik Fleming: Pleaded guilty to conspiracy to distribute ketamine and distribution resulting in death. His sentencing is scheduled for April 29.
- Kenneth Iwamasa: Pleaded guilty to conspiracy to distribute ketamine causing death. His sentencing is scheduled for April 22.
- Dr. Mark Chavez: Pleaded guilty to conspiracy to distribute ketamine. He was sentenced in December 2025 to eight months of home confinement.
- Dr. Salvador Plasencia: Pleaded guilty to four counts of distribution of ketamine. He was sentenced in December 2025 to 30 months in prison.
Prosecutors stated that Dr. Chavez formerly operated a ketamine clinic and that Dr. Plasencia had briefly treated Perry.